Bone morphogenetic protein-12 and -13 inhibit terminal differentiation of myoblasts, but do not induce their differentiation into osteoblasts

Biochem Biophys Res Commun. 1996 May 15;222(2):317-22. doi: 10.1006/bbrc.1996.0742.

Abstract

Effects of bone morphogenetic protein (BMP)-12 and BMP-13, new members of the BMP family which belong to the transforming growth factor (TGF)-beta superfamily, on terminal differentiation of myoblasts were examined in C2C12 and L-6 myoblasts. When the myoblasts were cultured with BMP-12 or BMP-13, the expression of the myosin heavy chain and the formation of multinucleated myotubes mRNA in L-6 cells. The inhibitory effects of BMP-12 and BMP-13 on myogenic differentiation were similar to the effects of BMP-2, though their potencies were lower than BMP-2. Unlike BMP-2, neither BMP-12 nor BMP-13 induced alkaline phosphatase activity in C2C12 myoblasts. The differences in the biological activities of these new BMPs suggest that the intracellular signalling pathway used by BMP-12 and BMP-13 differs from that of BMP-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / biosynthesis
  • Animals
  • Bone Morphogenetic Proteins
  • Cell Differentiation / drug effects*
  • Dose-Response Relationship, Drug
  • Enzyme Induction
  • Humans
  • Kinetics
  • Mice
  • Muscle, Skeletal / cytology*
  • Muscle, Skeletal / drug effects
  • Myosin Heavy Chains / biosynthesis
  • Osteoblasts / cytology*
  • Osteoblasts / drug effects
  • Proteins / pharmacology*
  • RNA, Messenger / biosynthesis
  • Recombinant Proteins / pharmacology
  • Transforming Growth Factor beta / pharmacology

Substances

  • Bone Morphogenetic Proteins
  • Proteins
  • RNA, Messenger
  • Recombinant Proteins
  • Transforming Growth Factor beta
  • Alkaline Phosphatase
  • Myosin Heavy Chains